What's next for hepatitis C virus research?

Hepatology

Volumn 63, Issue 5, 2016, Pages 1408-1410

  Lindenbach, Brett D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VACCINE; E1 PROTEIN, HEPATITIS C VIRUS; GLYCOPROTEIN E2, HEPATITIS C VIRUS; HEPATITIS VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; HEPATITIS C VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA REPLICATION; VIRUS MORPHOLOGY; VIRUS PARTICLE; BIOSYNTHESIS; CHEMISTRY; HEPACIVIRUS; IMMUNOLOGY; VIRION;

HEPACIVIRUS; RNA, VIRAL; VIRAL ENVELOPE PROTEINS; VIRAL HEPATITIS VACCINES; VIRION;

EID: 84961282404     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28494     Document Type: Article

References (10)

1. Walker CM, Grakoui A. Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection? Curr Opin Immunol 2015;35:137-143.
2. Houghton M. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses. Immunol Rev 2011;239:99-108.
3. Liang TJ. Current progress in development of hepatitis C virus vaccines. Nat Med 2013;19:869-878.
4. Folgori A, Capone S, Ruggeri L, Meola A, Sporeno E, Ercole BB, et al. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med 2006;12:190-197.
5. Barnes E, Folgori A, Capone S, Swadling L, Aston S, Kurioka A, et al. Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci Transl Med 2012;4:115ra111.
6. Swadling L, Capone S, Antrobus RD, Brown A, Richardson R, Newell EW, et al. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory. Sci Transl Med 2014;6:261ra153.
7. Lindenbach BD, Rice CM. The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 2013;11:688-700.
8. El Omari K, Iourin O, Kadlec J, Sutton G, Harlos K, Grimes JM, Stuart DI. Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1. Nat Commun 2014;5:4874.
9. Khan AG, Whidby J, Miller MT, Scarborough H, Zatorski AV, Cygan A, et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 2014;509:381-384.
10. Kong L, Giang E, Nieusma T, Kadam RU, Cogburn KE, Hua Y, et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science 2013;342:1090-1094.